Bloodstream Infection by Saccharomyces cerevisiae in Two COVID-19 Patients after Receiving Supplementation of Saccharomyces in the ICU

• DOI: 10.3390/jof6030098
• Publication Date: 2020-06-30T20:06:54Z
• Authors: Ioannis Ventoulis; Theopisti Sarmourli; Pinelopi Amoiridou; Paraskevi Mantzana; Maria Exindari; Georgia Gioula; Timoleon-Achillea...
• Keywords: Pandemic; Coronavirus

Co-infections have an unknown impact on the morbidity and mortality of new clinical syndrome called coronavirus disease 2019 (COVID-19). The is caused by pandemic SARS-CoV-2 it probably connected with severe traces in elements immune system. Apart from possible Aspergillus infections, particularly patients acute respiratory distress (ARDS), other fungal infections could occur, more easily, due to immunological dysregulation critical condition these patients. Probiotic preparations Saccharomyces are broadly used for prevention antibiotic-associated complications, especially intensive care units (ICU). On hand, organisms reported as agents invasive infection immunocompromised or critically ill We report two cases bloodstream hospitalised ICU, COVID-19, after supplementation.